Cardiocell™, bone marrow-derived mesenchymal stem cells for heart diseases

Cardiocell™ is designed for intracoronary implantation of autologous bone marrow-derived mesenchymal stem cells in patients with ischemic dilated cardiomyopathy. Cardiocell™ -treated patients benefit from symptomatic relief, improved exercise capacity and stamina, and reduction of angina. There is evidence of increased heart strength and contractility, and reduction of heart swelling and scar tissue.